University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) — Fairway, Kansas

University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) is a clinical research site located in Fairway, Kansas, United States 66205.

Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fairway

Browse all research sites in Kansas · View every site in Fairway

• University of Kansas Hospital
• University of Kansas Medical Center CTSU Fairway - Appendix A & B
• University of Kansas Medical Center
• The University of Kansas Cancer Center - Clinical Research Center - Fairway Office Park
• Kansas University Clinical Research Center
• University of Kansas Cancer Center /ID# 218144
• University of Kansas Cancer Center, Clinical Research Center, 4350 Shawnee Mission Parkway, MS 6004
• Kansas University Alzheimer's Disease Center (KUADC)
• The University of Kansas Alzheimer's Disease Research Center
• The University of Kansas Clini /ID# 162915
• University of Kansas Cancer Center /ID# 201292
• The University of Kansas Medical Center Research Institute

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038)?

University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) conducted?

University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma.

Is University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) accredited by Crixeo Clinical Trials?

University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.